Rymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform
Summary
While healthcare data management has remained inefficient and expensive, we believe Rymedis blockchain-based solution is having a meaningful impact on cost, connectivity, security, and user experience.The Rymedi platform, which currently supports Clemson University and many other large organizations throughout the world, removes the friction of a manual, paper filled operation to quickly connect with customers and patients and scale lab processes with higher testing throughput and lower total cost of ownership.Our decentralized data platform is diminishing roadblocks that healthcare systems have faced for far too long, said David Stefanich, CEO and Founder of Rymedi. Data entry errors and healthcare compliance issues slow the development of life-saving research, patient care, and occupational health processes. We are improving the overall healthcare experience with this technology and are proud to make a larger global impact as we scale our services with this round of funding.In the areas of occupational health, clinical trials, and laboratory information management systems, it automates data transfer with flexible interoperability, streamlines data entry with real-time results, and meets global regulatory compliance standards with unrivaled security. For healthcare companies, this portends both higher costs and lost revenue, and for consumers, a suboptimal care experience," said Sep Alavi, General Partner of White Star Capital. Rymedis innovative solution serves as the connectivity layer between all of these silos and is consistent with our thesis that the design space for programmable & decentralized blockchain backends is massive.
Funding
Review available funding amount, funding date, investors, and linked company information related to Rymedi Raises $9M to Expand Impact on Global Healthcare Infrastructure with Advanced Blockchain-Secured Data Platform in the interactive ISVWorld profile.